Molecular Therapy-Methods & Clinical Development

The aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella. Topics of particular interest within the journal''s scope include: Gene vector engineering and production, Methods for targeted genome editing and engineering, Methods and technology development for cell reprogramming and directed differentiation of pluripotent cells, Methods for gene and cell vector delivery, Development of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, Analysis of gene and cell vector biodistribution and tracking, Pharmacology/toxicology studies of new and next-generation vectors, Methods for cell isolation, engineering, culture, expansion, and transplantation, Cell processing, storage, and banking for therapeutic application, Preclinical and QC/QA assay development, Translational and clinical scale-up and Good Manufacturing procedures and process development, Clinical protocol development, Computational and bioinformatic methods for analysis, modeling, or visualization of biological data, Negotiating the regulatory approval process and obtaining such approval for clinical trials.

Molecular Therapy-Methods & Clinical Development是一本由Cell Press出版商出版的专业医学期刊，已被国际权威数据库SCIE收录。 期刊分区： 在中科院最新升级版分区表中，该刊分区信息为大类学科：医学2区，小类学科：医学：研究与实验 2区；在JCR（Journal Citation Reports）分区等级为Q2。 期刊范围： Molecular Therapy-Methods & Clinical Development发文范围涵盖MEDICINE, RESEARCH & EXPERIMENTAL等领域，旨在及时、准确、全面地报道国内外MEDICINE, RESEARCH & EXPERIMENTAL工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。